Article: Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading DES in First 'Real World, All Comers' Clinical Study.

Article: FDA approves drug-eluting stent for clogged heart ...
M2 Presswire;  April 24, 2003 ;     700+ words ... ... FDA approves drug-eluting stent for clogged heart arteries ... approved the first drug-eluting stent for angioplasty procedures ... procedure, but after nine months the patients who received the drug-eluting stent had a significantly lower ...

Article: Medtronic initiates drug-eluting stent trial.
Pharma Marketletter;  July 28, 2003 ;     274 words ...US firm Medtronic has initiated its ENDEAVOR II pivotal clinical study for its Endeavor drug-eluting stent, utilizing the drug ABT-578. The primary endpoint of the study is target vessel failure at nine months.

Article: ENDEAVOR I Clinical Study Demonstrates Positive Results of ...
Business Wire;  September 17, 2003 ;     700+ words ... ... Endeavor(TM) Drug Eluting Stent for the treatment of ... Medtronic's Endeavor Drug Eluting Stent for the safe and effective ... Revascularization (TLR) at nine months and late loss at 12 ... that the Endeavor Drug Eluting Stent is meeting its clinical ...

Article: Medtronic Receives CE Mark for Endeavor(R) Resolute ...
Business Wire;  October 22, 2007 ;     700+ words ... ... internally developed drug-eluting stent options for the treatment ... for use on a drug-eluting stent. The BioLinx polymer ... now have a new drug-eluting stent for our patients with ... procedures through nine months and had experienced ...

Article: Conor Medsystems Initiates COSTAR II Pivotal Drug-Eluting ...
PR Newswire;  May 24, 2005 ;     700+ words ... ... TAXUS(R) Express2(TM) drug-eluting stent in the treatment of de novo lesions ... undergo follow-up angiography at nine months. Enrollment is anticipated to ... the next-generation of drug-eluting stent technologies, allowing for greater ...

Article: MIV Preliminary Nine-Month Human Data Affirms Excellent Safety ...
Business Wire;  March 31, 2008 ;     700+ words ... ... VESTAsync[TM] drug-eluting stent suggest that the stent ... Based Sirolimus-Eluting Stent for the Treatment of ... Generation Drug-Eluting Stent System" concluded ... of 12 patients at nine months found a late-lumen ...

Article: FDA Approves Abbott's XIENCE(TM) V Drug Eluting ...
PR Newswire Europe;  July 2, 2008 ;     700+ words ... ... XIENCE V, Only Drug Eluting Stent to Demonstrate Superiority ... XIENCE V is the only drug eluting stent to have demonstrated superiority ... true next-generation drug eluting stent with clinically important ... to the stented vessel) at nine months, with an observed 20 ...